Oslo, Norway

Karianne Giller Fleten

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Karianne Giller Fleten Revolutionizing Cancer Treatment in Oslo

Introduction

Karianne Giller Fleten is a pioneering inventor based in Oslo, Norway, whose groundbreaking work in the field of anti-cancer treatments has earned him recognition and acclaim. With a keen focus on utilizing innovative technologies to combat cancer, Fleten has made significant contributions to the medical field.

Latest Patents

Fleten holds a notable patent for his invention titled "PACA and cabazitaxel for anti-cancer treatment." This patent involves the encapsulation of an active ingredient into poly (alkyl cyanoacrylate) nanoparticles for use in anti-cancer treatments through intraperitoneal administration. His innovative approach showcases his commitment to developing effective and targeted cancer therapies.

Career Highlights

During his career, Fleten has worked with esteemed organizations such as Sintef TTO AS and Oslo Universitetssykehus HF (Oslo University Hospital). His collaborations with these institutions have allowed him to translate his research into practical applications that have the potential to improve patient outcomes and revolutionize cancer treatment.

Collaborations

Throughout his career, Fleten has collaborated with accomplished professionals in the field of oncology. Notable coworkers include Yrr Morch and Einar Sulheim, who have worked alongside Fleten to further advance their collective research and developments in the fight against cancer. These collaborations have led to interdisciplinary breakthroughs that have pushed the boundaries of anti-cancer treatment strategies.

Conclusion

Karianne Giller Fleten's innovative contributions to the field of cancer treatment exemplify his dedication to improving healthcare outcomes and addressing pressing medical challenges. His pioneering work with poly (alkyl cyanoacrylate) nanoparticles signifies a promising advancement in the fight against cancer, offering hope to patients and researchers alike. Fleten's legacy as an inventive mind in Oslo continues to inspire future generations of innovators in the pursuit of transformative healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…